Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 205-211

  Higashiyama, Masahiko ^a   Doi, Osamu ^a   Kodama, Ken ^a   Yokouchi, Hideoki ^a   Adachi, Masashi ^b   Huang, Cheng Long ^b   Taki, Toshihiko ^b   Kasugai, Tsutomu ^a   Ishiguro, Shingo ^a   Nakamori, Shoji ^a   Miyake, Masayuki ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; MOTILITY RELATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE;

EID: 0030972183     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C     Document Type: Article

References (26)

1. ADACHI, M., TAKI, T., IEKI, Y., HUANG, C.-L., HIGASHIYAMA, M. and MIYAKE, M., Correlation of KAI1/CD82-gene expression with good prognosis of patients with non-small-cell lung cancer. Cancer Res., 56, 1751-1755 (1996).
2. AMIOT, M., Identification and analysis of cDNA clones encoding CD53: a pan-leukocyte antigen related to membrane transport proteins. J. Immunol., 145, 4322-4325 (1990).
3. BOUCHEIX, C., BENOIT, P., FRACHET, P., BILLARD, M., WORTHINGTON, R.E., GAGNON, J. and UZAN, G., Molecular cloning of the CD9 antigen. J. biol. Chem., 266, 117-122 (1991).
4. BRADSTOCK, K., MATTHEWS, J., BENSON, E., PAGE, F. and BISHOP, L., Prognostic value of immunophenotyping in acute myeloid leukemia. Blood, 84, 1220-1225 (1994).
5. CLASSON, B.J., WILLIAMS, A.F., WILLIS, A.C., SEED, B. and STAMENKOVIC, I., The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J. exp. Med., 169, 1497-1502 (1989).
6. DONG, J-T., LAMB, P.W., RINKER-SCHAEFFER, C.W., VUKANOVIC, J., ICHIKAWA, T., ISAACS, J.T. and BARRETT, J.C., KAI-1, a metastatic suppressor gene for prostatic cancer on human chromosome 11p11.2. Science, 268, 884-886 (1995).
7. GAUGITSCH, H.W., HOFER, E., HUBER, N.E., SCHNABL, E. and BAUMRUKER, T., A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Europ. J. Immunol., 21, 377-383 (1991).
8. GRIFFITH, L., SLUPSKY, J., SEEHAFER, J., BOSHKOV, L. and SHAW, A.R.E., Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood, 78, 1753-1759 (1991).
9. HIGASHIYAMA, M., TAKI, T., IEKI, Y. ADACHI, M., HUANG, C.-L., KOH, T., KODAMA, K., DOI, O. and MIYAKE, M., Reduced-motility-related protein-1 (MRP-1/CD9)-gene expression as a factor of poor prognosis in non-small-cell lung cancer. Cancer Res., 55, 6040-6044 (1995a).
10. HIGASHIYAMA, S., IWAMOTO, R., GOISHI, K., RAAB, G., TANIGUCHI, N., KLAGSBRUN, M. and MEKADA, E., The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-bindina EGF-like growth factor. J. Cell Biol., 128, 929-938 (1995b).
11. HOREJSI, V. and VLCEK, C., Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett., 288, 1-4 (1991).
12. HOTTA, H., ROSS, A.H., HUEBNER, K., ISOBE, M., WENDEBORN, S., CHAO, M.V., RICCIARDI, R.P., TSUJIMOTO, Y., CROCE, C.M. and KOPROWSKI, H., Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res., 48, 2955-2962 (1988).
13. IKEYAMA, S., KOYAMA, M., YAMAOKO, M., SASADA, R. and MIYAKE, M., Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. exp. Med., 177, 1231-1237 (1993).
14. LANZA, F., WOLF, D., FOX, C.F., KIEFFER, N., SEYER, J.M., FRIED, V.A., COUGHLIN, S.R., PHILLIPS, D.R. and JENNINGS, L.K., cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins. J. biol. Chem., 266, 10638-10645 (1991).
15. MASELLIS-SMITH, A. and SHAW, A.R.E., CD9-regulated adhesion. Anti-CD9 monoclonal antibody induces pre-B-cell adhesion to bone-marrow fibroblasts through de novo recognition of fibronectin. J. Immunol., 152, 2768-2777 (1994).
16. MIYAKE, M., KOYAMA, M., SENO, M. and IKEYAMA, S., Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. exp. Med., 174, 1347-1354 (1991).
17. MIYAKE, M., NAKANO, K., IEKI, Y. ADACHI, M., HUNANG, C.-L., ITOI, S., KOH, T. and TAKI, T., Motility-related-protein-1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res., 55, 4127-4131 (1995).
18. MOUNTAIN, C.F., A new international staging system for lung cancer. Chest, 89, 225S-233S (1986).
19. OREN, R., TAKAHASHI, S., DOSS, C., LEVY, R. and LEVY, S., TAPA-1, the target of an anti-proliterative antibody, defines a new family of trans-membrane proteins. Mol. cell Biol., 10, 4007-4015 (1990).
20. RUBINSTEIN, E., LE-NAOUR, F., BILLARD, M., PRENANT, M. and BOUCHEIX, C., CD9 antigen is an accessory sub-unit of the VLA-integrin complexes. Europ. J. Immunol., 24, 3005-3013 (1994).
21. SI, Z. and HERSEY, P., Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int. J. Cancer, 54, 37-43 (1993).
22. SZALA, S., KASAI, Y., STEPLEWSKI, Z., RODECK, U., KOPROWSKI, H. and LINNENBACH, A.J., Molecular cloning of cDNA tor the human tumor-associated antigen CO-029 and identification of related trans-membrane antigen. Proc. nat. Acad. Sci. (Wash.), 87, 6833-6837 (1990).
23. THOMAS, X., ARCHIMBAUD, E., CHARRIN, C., MAGAUD, J.P. and FIERE, D., CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia, 9, 249-253 (1995).
24. r-23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J. Immunol., 144, 3195-3200 (1990).
25. WRIGHT, M.D. and TOMLINSON, M.G., The ins and outs of the trans-membrane-4 superfamily. Immunol. Today, 15, 588-594 (1995).
26. YATOMI, Y., OZAKI, Y., SATOH, K. and KUME, S., Anti-CD9 monoclonal antibody elicits staurosporine-inhibitable phosphatidylinositol 4.5-bisphosphate hydrolysis, phosphatidylinositol 3.4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets. FEBS Lett., 322, 285-290 (1993).